Bréchot C, Nalpas B, Couroucé A M, Duhamel G, Callard P, Carnot F, Tiollais P, Berthelot P
N Engl J Med. 1982 Jun 10;306(23):1384-7. doi: 10.1056/NEJM198206103062302.
We compared the presence of serologic markers of hepatitis B virus (HBV) infection with the presence of the viral DNA in the livers of patients with alcoholic liver disease with or without hepatocellular carcinoma. Among 51 patients with various kinds of alcoholic liver disease but without hepatocellular cancer, 19 had one or more serologic markers of HBV, but only three had viral surface antigen in their serum. These three patients, as well as three others who had HBV antibodies but no viral antigen in their serum and two others who had no serologic markers of any kind, had HBV DNA in their liver cells. In at least five of the eight patients with viral DNA in the liver, the DNA was integrated into the genome. Among 20 patients with alcoholic cirrhosis and hepatocellular carcinoma, nine of the 16 tested had serologic markers of HBV infection, but all 20 had HBV DNA integrated into the genome of the neoplastic liver cells. These data suggest that HBV plays a part in the pathogenesis of primary liver-cell cancer in alcoholics.
我们比较了患有或未患有肝细胞癌的酒精性肝病患者肝脏中乙型肝炎病毒(HBV)感染的血清学标志物与病毒DNA的存在情况。在51例患有各种酒精性肝病但无肝细胞癌的患者中,19例有一项或多项HBV血清学标志物,但血清中仅有3例有病毒表面抗原。这3例患者,以及另外3例血清中有HBV抗体但无病毒抗原的患者和另外2例无任何类型血清学标志物的患者,其肝细胞中均有HBV DNA。在肝脏中有病毒DNA的8例患者中,至少有5例的DNA整合到了基因组中。在20例酒精性肝硬化合并肝细胞癌的患者中,16例接受检测的患者中有9例有HBV感染的血清学标志物,但所有20例患者的肿瘤肝细胞基因组中均有HBV DNA整合。这些数据表明,HBV在酒精性肝病患者原发性肝细胞癌的发病机制中起作用。